DEF 14A Filing

Company

Protagenic Therapeutics, Inc.\new

Filed

October 31, 2001

Period of Report

November 19, 2001

Accession Number

0000921895-01-500463

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →